| |
| [ JPM Week SF 2026 ] |
Bridging Discovery To Clinic - How AI & Tech Transforming Therapeutics
|
| With Jonathan Steckbeck (Founder/CEO, Peptilogics), Andreas Pfenning (Prof. Computational Biology, CMU), Amoolya Singh (CTO, DELFI), Megan Shaw (CEO, Pittsburgh Life Sciences Alliance). |
| Venue, To Be Announced, San Francisco |
|
Jan 11 (Sun) , 2026 @ 02:00 PM
| |
FREE |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Bridging Discovery to Clinic: How AI & Digital Technologies Are Transforming Therapeutics
Discover how technology is transforming therapeutics, reducing time-to-market, & cutting development costs.
We are entering a new era where artificial intelligence, digital technology, & next-generation engineering are converging to reshape the entire therapeutic lifecycle - from discovery & design to development, trials, manufacturing, & patient delivery.
This convergence is redefining how quickly & affordably treatments reach patients, marking a pivotal shift in efficiency, precision, & innovation velocity across life sciences. It is no surprise that capital allocation is concentrating in fewer, later-stage deals, with AI-driven discovery remaining a key investment bright spot. Join us for an afternoon panel discussion exploring how promising, high-impact companies are leveraging technology to reimagine the therapeutic lifecycle through AI, data, & digital integration.
Panelists:
Jonathan Steckbeck, CEO & Founder, Peptilogics
Andreas Pfenning, Associate Professor of Computational Biology, Carnegie Mellon University
Amoolya Singh, Chief Technology Officer, DELFI Diagnostics
Megan Shaw (moderator), President & CEO, Pittsburgh Life Sciences Alliance
Co-hosted by the CMU Swartz Center for Entrepreneurship & the Pittsburgh Life Sciences Alliance.
Sunday, January 11, 2026
2-4 PM (PT)
RSVP requested by Jan 2. Check back often for speaker updates.
|
|
|
|
|
|
|
|
